Suven Life Sciences Limited - Laporan Laba Rugi (TTM)

Suven Life Sciences Limited
IN ˙ NSEI
₹ 222.80 ↑10.60 (5.00%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Suven Life Sciences Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 221 209 141 147 69 98 120 135 167 153 136 139 125 120 117 89 84 76 67 75
Change (%) -5.69 -32.57 4.10 -53.21 42.59 22.26 12.83 23.75 -8.57 -10.89 1.90 -9.58 -4.40 -2.35 -23.87 -5.47 -9.99 -12.12 12.93
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 0 0 1 1 1 1 24 24 24 24 6 6 6 6 8 8 8 8 8 8
Change (%) 0.00 354.19 0.00 0.00 0.00 2,259.46 0.00 0.00 0.00 -76.75 0.00 0.00 0.00 45.76 0.00 0.00 0.00 -8.87 0.00
% of Revenue 0.10 0.11 0.73 0.70 1.50 1.05 20.36 18.04 14.58 15.95 4.16 4.08 4.52 4.72 7.05 9.26 9.80 10.88 11.29 10.00
Gross Operating Profit 221 208 140 145 68 97 95 111 143 128 130 133 120 114 117 81 76 67 59 68
Change (%) -5.70 -32.99 4.13 -53.59 43.24 -1.59 16.11 28.98 -10.04 1.61 1.98 -9.99 -4.61 2.49 -30.92 -6.03 -11.08 -12.52 14.58
% of Revenue 99.90 99.89 99.27 99.30 98.50 98.95 79.64 81.96 85.42 84.05 95.84 95.92 95.48 95.28 100.00 90.74 90.20 89.12 88.71 90.00
SG&A 176 188 185 195 189 194 210 208 208 204 186 190 184 195 190 184 192 183 211 224
Change (%) 6.70 -1.25 4.95 -2.95 2.96 8.14 -0.97 -0.31 -1.46 -8.94 2.30 -3.31 5.63 -2.22 -3.11 4.09 -4.84 15.65 6.09
% of Revenue 79.49 89.93 131.71 132.78 275.40 198.85 175.90 154.38 124.37 134.04 136.97 137.52 147.05 162.48 162.69 207.07 228.02 241.08 317.27 298.05
R&D 819 809 710 990 1,015 1,089 1,064 861 831 1,019 1,154 1,219 1,230 1,158 1,144 1,146 1,416 1,342 1,440 1,605
Change (%) -1.19 -12.21 39.40 2.54 7.23 -2.29 -19.06 -3.45 22.59 13.20 5.67 0.95 -5.88 -1.19 0.12 23.64 -5.29 7.31 11.51
% of Revenue 369.97 387.65 504.70 675.82 1,481.07 1,113.71 890.05 638.51 498.16 667.97 848.49 879.87 982.28 967.14 978.60 1,286.96 1,683.29 1,771.30 2,162.95 2,135.72
OpEx 1,102 1,082 974 1,263 1,285 1,373 1,382 1,187 1,166 1,347 1,455 1,528 1,534 1,474 1,462 1,455 1,735 1,656 1,778 1,988
Change (%) -1.85 -10.01 29.68 1.76 6.84 0.66 -14.05 -1.79 15.54 7.99 5.00 0.39 -3.92 -0.79 -0.45 19.20 -4.55 7.41 11.78
% of Revenue 498.05 518.35 691.80 861.77 1,874.09 1,404.17 1,156.14 880.68 698.90 883.23 1,070.34 1,102.93 1,224.48 1,230.68 1,250.32 1,634.99 2,061.59 2,186.21 2,672.07 2,644.85
Operating Income -881 -873 -833 -1,116 -1,216 -1,275 -1,262 -1,053 -999 -1,195 -1,319 -1,389 -1,409 -1,354 -1,343 -1,366 -1,651 -1,580 -1,712 -1,913
Change (%) -0.88 -4.62 34.00 8.97 4.82 -0.99 -16.60 -5.07 19.57 10.40 5.32 1.38 -3.88 -0.81 1.75 20.80 -4.27 8.34 11.74
% of Revenue -398.05 -418.35 -591.80 -761.77 -1,774.09 -1,304.17 -1,056.14 -780.68 -598.90 -783.23 -970.34 -1,002.93 -1,124.48 -1,130.68 -1,148.49 -1,534.99 -1,961.59 -2,086.21 -2,572.07 -2,544.85
Interest Expense -8 -8 -8 -8 -6 -7 -5 -5 -4 -3 -4 -4 -3 -3 -2 -1 -1 -1 -0 -0
Change (%) 9.68 -1.56 -5.22 -18.08 6.49 -21.05 -9.62 -16.73 -16.40 23.95 -12.17 -7.54 -8.45 -48.67 -17.74 -20.18 -26.44 -39.08 -49.57
% of Revenue -3.41 -3.97 -5.79 -5.27 -9.24 -6.90 -4.45 -3.57 -2.40 -2.20 -3.05 -2.63 -2.69 -2.58 -1.35 -1.46 -1.24 -1.01 -0.70 -0.31
Net Income -745 -761 -722 -1,009 -1,135 -1,228 -1,220 -991 -940 -1,114 -1,183 -1,260 -1,155 -1,062 -1,051 -1,090 -1,460 -1,433 -1,607 -1,842
Change (%) 2.12 -5.19 39.80 12.53 8.19 -0.66 -18.76 -5.16 18.54 6.14 6.57 -8.33 -8.09 -1.04 3.76 33.90 -1.81 12.14 14.61
% of Revenue -336.71 -364.59 -512.69 -688.50 -1,655.85 -1,256.35 -1,020.82 -735.05 -563.32 -730.36 -869.95 -909.79 -922.33 -886.73 -898.62 -1,224.79 -1,734.89 -1,892.54 -2,415.11 -2,450.90

Source: Capital IQ

Other Listings
IN:530239
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista